PMC:7402624 / 4004-4262 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"101","span":{"begin":91,"end":100},"obj":"Species"},{"id":"102","span":{"begin":237,"end":245},"obj":"Species"}],"attributes":[{"id":"A101","pred":"tao:has_database_id","subj":"101","obj":"Tax:2697049"},{"id":"A102","pred":"tao:has_database_id","subj":"102","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"this previous work provokes questions about the potential diversity of immune responses to SARS-CoV2 and the relationship of this immune response diversity to clinical disease. However, many studies describe small cohorts or even single patients, limiting a "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T31","span":{"begin":91,"end":95},"obj":"Disease"}],"attributes":[{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"this previous work provokes questions about the potential diversity of immune responses to SARS-CoV2 and the relationship of this immune response diversity to clinical disease. However, many studies describe small cohorts or even single patients, limiting a "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T47","span":{"begin":256,"end":257},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"this previous work provokes questions about the potential diversity of immune responses to SARS-CoV2 and the relationship of this immune response diversity to clinical disease. However, many studies describe small cohorts or even single patients, limiting a "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T20","span":{"begin":71,"end":87},"obj":"http://purl.obolibrary.org/obo/GO_0006955"},{"id":"T21","span":{"begin":130,"end":145},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"this previous work provokes questions about the potential diversity of immune responses to SARS-CoV2 and the relationship of this immune response diversity to clinical disease. However, many studies describe small cohorts or even single patients, limiting a "}